Overview
Tribulus terrestris is a flowering plant extract that has become one of the most popular natural supplements for athletic performance, sexual health, and hormonal balance. Traditionally used in Ayurvedic and Chinese medicine for centuries, this supplement has gained widespread attention in modern fitness and wellness circles as a purported testosterone booster.
The plant contains active compounds called steroidal saponins—primarily protodioscin—along with flavonoids and antioxidants. These constituents are believed to influence hormonal pathways, enhance blood flow, and support overall health. However, the scientific evidence for many of these claims varies considerably. While some areas show genuine promise, particularly for sexual function and mild anti-inflammatory effects, other popular claims about muscle growth and fat loss lack meaningful human evidence.
This comprehensive guide examines what the research actually shows about Tribulus, separating marketing claims from evidence-based benefits.
How It Works: Mechanism of Action
Tribulus terrestris exerts its effects through several proposed mechanisms:
Hormonal Signaling
The primary active compounds, steroidal saponins like protodioscin, are thought to stimulate luteinizing hormone (LH) release from the pituitary gland. This signaling cascade may theoretically prompt the testes to increase testosterone synthesis. However, this effect has proven inconsistent in human trials, with most studies showing weak or absent testosterone elevation in healthy men.
Androgen Receptor Activity
Tribulus exhibits weak androgen receptor agonist activity, meaning its compounds may bind to androgen receptors in tissues—though less potently than testosterone itself. This mechanism may contribute to some observed benefits, particularly in sexual function, even without significant testosterone elevation.
Nitric Oxide Pathways
The supplement may influence nitric oxide pathways in penile tissue, improving blood flow and contributing to pro-erectile effects. This vascular mechanism may explain why sexual function improvements have been more consistent than testosterone changes.
Antioxidant & Anti-inflammatory Effects
Tribulus contains flavonoids and other antioxidants that may protect cells from oxidative damage. Some evidence suggests it protects Leydig cells (which produce testosterone) from oxidative stress, and may modulate DHEA levels through antioxidant mechanisms.
DHEA Modulation
Some research indicates Tribulus may influence DHEA (dehydroepiandrosterone) levels, though the clinical significance of this effect remains unclear.
Evidence by Health Goal
Sexual Health & Erectile Function — Tier 3
Evidence Level: Probable efficacy
Sexual health is where Tribulus shows its strongest evidence base. Multiple randomized controlled trials and meta-analyses demonstrate consistent improvements in sexual function markers.
A meta-analysis of 8 RCTs found that Tribulus improved IIEF-5 scores (International Index of Erectile Function) by 4.21 points versus baseline (p<0.00001) and outperformed placebo by 3.23 points. For the more comprehensive IIEF-15 assessment, improvements reached 15.88 points versus baseline and 14.44 points over placebo (p=0.001).
Importantly, a meta-analysis of 10 studies revealed that 3 of 5 studies assessing erectile dysfunction showed improvement with 400-750 mg daily for 1-3 months. However, 8 of 10 studies showed no significant changes in total androgen profiles—suggesting that sexual improvements may occur through mechanisms independent of testosterone elevation, possibly via enhanced nitric oxide production or improved vascular function.
Female sexual desire and arousal also showed improvements in some trials, though the evidence base is smaller than for male sexual function.
Hormonal Balance — Tier 3
Evidence Level: Probable efficacy for specific populations
Claims about Tribulus as a testosterone booster warrant careful examination. While the supplement has been heavily marketed for testosterone elevation, the evidence is inconsistent and population-dependent.
In healthy men without baseline hormonal deficiency, most studies show minimal or no testosterone elevation. However, in aging men with declining testosterone, one observational study of 30 men found that 750 mg daily for 3 months increased total testosterone and free testosterone with statistical significance (p<0.05), while also improving erectile function as measured by IIEF-5 scores.
The critical takeaway: Tribulus may benefit men with existing hormonal deficiencies but shows weak effects in men with normal baseline testosterone levels.
Athletic Performance & Strength — Tier 2
Evidence Level: Unproven efficacy
Despite heavy marketing to athletes, human studies consistently fail to demonstrate meaningful improvements in strength, power output, or body composition.
A double-blind RCT in elite rugby league players (n=22) found no significant improvement in strength or lean mass gains after 5 weeks of 450 mg daily Tribulus versus placebo. In resistance-trained males (n=15) receiving 3.21 mg/kg daily for 8 weeks, there were no improvements in body composition or exercise performance. A more recent RCT in CrossFit athletes (n=30) receiving 770 mg daily for 6 weeks found that Tribulus increased testosterone levels (p<0.05) but did not improve exercise performance or body composition.
Fat Loss — Tier 2
Evidence Level: No proven efficacy
Four human RCTs consistently demonstrate null or minimal effects on body composition. The CrossFit study mentioned above found no significant changes in body fat percentage after 6 weeks at 770 mg daily versus placebo. In resistance-trained males, 8 weeks of supplementation at 3.21 mg/kg daily produced no changes in body weight or percentage fat.
While animal studies suggest potential mechanisms through anti-inflammatory and metabolic pathways, these have not translated to meaningful human weight loss outcomes.
Muscle Growth — Tier 2
Evidence Level: No proven efficacy
Similar to strength gains, Tribulus does not meaningfully enhance muscle growth in humans. The same resistance training study showing no performance improvements also showed no improvement in body composition. The CrossFit RCT found no enhancement to body composition, strength, or muscle damage recovery.
Anti-Inflammation — Tier 3
Evidence Level: Probable efficacy
This area shows more promise, though sample sizes remain small and results lack independent replication.
In a 13-subject RCT with crossover design, Tribulus terrestris supplementation reduced white blood cell count elevation, protein carbonyl elevation, and creatine kinase activity after acute exhaustive exercise, with improvements in GSH/GSSG ratio maintained at 2 hours post-exercise (p=0.034). In trained athletes (n=30) over 6 weeks, Tribulus supplementation reduced C-reactive protein (CRP) levels compared to placebo (p<0.05), with slight downward trends in LDH and other inflammation biomarkers.
These effects appear more pronounced in response to acute exercise stress rather than in resting inflammatory states.
Joint Health — Tier 2
Evidence Level: Promise without clinical proof
Animal models show substantial promise. In MIA-induced osteoarthritis in rats, Tribulus extract attenuated osteoarthritis progression by downregulating inflammatory markers (NOS2, COX-2, TNF-α, IL-6) and reducing MMP-2/MMP-9 expression.
However, human evidence is limited to one RCT (n=13) showing that Tribulus maintained higher GSH/GSSG ratio at 2 hours post-exercise and reduced protein carbonyls and CK activity, but did not significantly improve delayed-onset muscle soreness (DOMS) or knee joint range of motion.
Heart Health — Tier 3
Evidence Level: Probable efficacy
Several human trials suggest cardiovascular benefits. In prehypertensive individuals, 6g daily for 2 months produced systolic/diastolic blood pressure reductions of -7.7/-5.5 mmHg versus -1.9/-0.2 mmHg for placebo.
In diabetic women (n=98), 1000 mg daily for 3 months produced significant reductions in total cholesterol and LDL compared to placebo, with also-significant reductions in fasting glucose. However, evidence is limited by small sample sizes, short durations, and lack of independent replication.
Cognition — Tier 2
Evidence Level: Animal promise, unproven in humans
Animal studies show consistent neuroprotective effects. In MCAO stroke rats, Tribulus saponin extract significantly decreased infarction volume and improved neurobehavioral scores through downregulation of inflammatory markers and inhibition of the TLR4/MyD88/NF-κB pathway.
In aged male rats, Tribulus extract combined with swimming exercise significantly increased catalase and total antioxidant capacity while decreasing malondialdehyde, with improved spatial memory in Y-maze testing and avoidance memory in shuttle box tasks.
However, only 2 human RCTs exist, and the evidence in humans remains unproven.
Mood & Stress — Tier 2
Evidence Level: Unproven in humans
Animal models show anxiolytic and antidepressant-like effects. A scopolamine-induced amnesia zebrafish model showed anxiolytic effects with Tribulus 1-6 mg/L for 10 days. However, a human RCT (n=15) found no significant changes in mood states in resistance-trained males receiving 3.21 mg/kg daily for 8 weeks versus placebo.
Energy — Tier 2
Evidence Level: Weak efficacy
While Tribulus shows antioxidant effects during exercise (maintaining higher GSH/GSSG ratio and reducing TBARS and protein carbonyls), human RCTs found no meaningful improvements in exercise performance or body composition. One study showed it increased testosterone levels but without corresponding performance enhancements.
Injury Recovery — Tier 1
Evidence Level: No proven efficacy
The 13 articles reviewed contain zero human RCTs specifically testing Tribulus for injury/wound healing. Notably, one human case report documented severe hepatotoxicity: a 46-year-old developed total bilirubin of 48 mg/dL and creatinine of 7.1 after 2 months of daily supplementation, requiring hospitalization and plasmapheresis.
Liver Health — Tier 2
Evidence Level: Promising animal evidence, limited human data
Animal studies show hepatoprotective potential. In rats exposed to carboplatin, Tribulus terrestris (1.5 g/kg) significantly reduced serum AST levels and reversed malondialdehyde elevation while restoring glutathione levels, with histopathological confirmation of hepatic recovery.
However, the case report of severe hepatotoxicity mentioned above suggests caution is warranted, particularly at high doses or with prolonged use.
Immune Support — Tier 2
Evidence Level: No proven efficacy
A meta-analysis of 7 studies found no positive effects on immune system response in physically active adults despite improvements in lipid profiles. A human RCT (n=20) of 750 mg daily for 4 weeks did not affect PHA-induced lymphocyte proliferation or production of IL-2, IL-4, IL-10, or IFN-γ, despite increasing serum free testosterone by 38%.
Skin & Hair — Tier 2
Evidence Level: Limited human evidence
In a human RCT (n=60, 8 weeks), a Tribulus-containing herbal extract reduced both inflammatory and non-inflammatory acne lesions with statistical significance (p<0.05) and confirmed reduced IL-1α, IL-8, and keratin 16 by immunohistochemistry.
In mice, oral Tribulus extract increased MSH expression positivity in hair follicle melanocytes to 75% versus 18.75% in controls (p<0.01), suggesting potential for hair pigmentation. However, large-scale human trials are lacking.
Gut Health — Tier 2
Evidence Level: Animal promise, no human data
In spontaneously hypertensive rats, stir-fried Tribulus terrestris polysaccharides attenuated hypertension, modulated gut microbiota, increased short-chain fatty acids, and enhanced intestinal barrier function more effectively than unprocessed polysaccharides.
In type 2 diabetes rats, Tribulus water extract improved glucolipid metabolism, ameliorated intestinal barrier integrity, and altered intestinal microbiota composition. However, no human efficacy evidence exists.
Longevity — Tier 2
Evidence Level: Unproven in humans
Animal models suggest potential effects on aging-related markers. In aging rats exposed to stanozolol, Tribulus 50-100 mg/kg significantly reduced malondialdehyde levels and increased TERT, PI3K, and Akt gene expression, suggesting improved oxidative stress and telomere function.
Human data is restricted to improvements in sexual function and testosterone in aging men, with no direct measurement of aging biomarkers or lifespan outcomes.